| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Centre de Lutte contre le Cancer Paul Strauss, 3, rue de la Porte de l'Hôpital, 67085 [D. M., J. A., R. M., M. E., G. M.]; Laboratoire de Génétique Moléculaire des Eucaryotes du CNRS, Unité 184 de Biologie Moléculaire et de Génie Génétique de l'INSERM, Institut de Chimie Biologique, Faculté de Médecine, 11, rue Human, 67085 [C. W., M-C. R., P. C., P. B.]; Laboratoire d'Anatomie Pathologique, 29, rue Oberlin, 67000 [A. E.]; Clinique Sainte Barbe, 67000 [G. B.]; and Service d'Anatomie Pathologique Générale, Centre Hospitalier Universitaire, Hôpital de Hautepierre, 1, avenue Molière, 67098 [N. R.]; Strasbourg Cedex, France
Matrix metalloproteinases are believed to play an important role in tumor invasion and metastasis. To examine the expression of the stromelysin 3 (ST3) gene, a new member of the matrix metalloproteinase gene family, 111 head and neck squamous cell carcinomas and 21 metastatic lymph nodes were analyzed by Northern blot. ST3 gene expression was observed in 106 carcinomas and 19 metastatic nodes, but in only 2 of 60 samples of corresponding normal tissue tested in parallel. ST3 RNA, by in situ hybridization, and ST3 protein, by immunohistochemical analysis, were specifically detected in fibroblastic cells immediately surrounding invasive cancer cells. This fibroblastic expression of the ST3 gene is characteristic among the matrix metalloproteinase genes known to be overexpressed in head and neck carcinomas, since stromelysin 2 transcripts were specifically detected in neoplastic cells, and type I collagenase transcripts in both neoplastic cells and stromal fibroblasts. Furthermore, there was a highly significant positive correlation (P < 0.0001) between ST3 RNA levels and local invasiveness by the cancer cells, suggesting that enhanced expression of the ST3 gene may contribute to the neoplastic phenotype in head and neck carcinomas.
1 Supported by funds from the Ligue Nationale Française contre le Cancer, the Comité du Bas-Rhin de la Ligue contre le Cancer, the Centre National de la Recherche Scientifique, the Institut National de la Santé et de la Recherche Médicale, the Centre Hospitalier Universitaire Régional, the Association pour la Recherche sur le Cancer, and the Fondation Jeantet.
2 To whom requests for reprints should be addressed.
Received 4/28/92. Accepted 10/20/92.
This article has been cited by other articles:
![]() |
S. Choi and J.N. Myers Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy Journal of Dental Research, January 1, 2008; 87(1): 14 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sulek, R. A. Wagenaar-Miller, J. Shireman, A. Molinolo, D. H. Madsen, L. H. Engelholm, N. Behrendt, and T. H. Bugge Increased Expression of the Collagen Internalization Receptor uPARAP/Endo180 in the Stroma of Head and Neck Cancer J. Histochem. Cytochem., April 1, 2007; 55(4): 347 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Jones, M. J. Humphreys, F. Campbell, J. P. Neoptolemos, and M. T. Boyd Comprehensive Analysis of Matrix Metalloproteinase and Tissue Inhibitor Expression in Pancreatic Cancer: Increased Expression of Matrix Metalloproteinase-7 Predicts Poor Survival Clin. Cancer Res., April 15, 2004; 10(8): 2832 - 2845. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Rizvi, J. S. Humphrey, E. A. Ness, M. D. Johnson, E. Gupta, K. Williams, D. J. Daly, D. Sonnichsen, D. Conway, J. Marshall, et al. A Phase I Study of Oral BMS-275291, a Novel Nonhydroxamate Sheddase-Sparing Matrix Metalloproteinase Inhibitor, in Patients with Advanced or Metastatic Cancer Clin. Cancer Res., March 15, 2004; 10(6): 1963 - 1970. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Yang, Z. Xu, H. Wu, H. Zhu, X. Wu, and W. N. Hait Overexpression of Extracellular Matrix Metalloproteinase Inducer in Multidrug Resistant Cancer Cells Mol. Cancer Res., April 1, 2003; 1(6): 420 - 427. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Andl, T. Mizushima, H. Nakagawa, K. Oyama, H. Harada, K. Chruma, M. Herlyn, and A. K. Rustgi Epidermal Growth Factor Receptor Mediates Increased Cell Proliferation, Migration, and Aggregation in Esophageal Keratinocytes in Vitro and in Vivo J. Biol. Chem., January 10, 2003; 278(3): 1824 - 1830. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. O-charoenrat, P. H. Rhys-Evans, and S. A. Eccles Expression of Matrix Metalloproteinases and Their Inhibitors Correlates With Invasion and Metastasis in Squamous Cell Carcinoma of the Head and Neck Arch Otolaryngol Head Neck Surg, July 1, 2001; 127(7): 813 - 820. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ishizuya-Oka, Q. Li, T. Amano, S. Damjanovski, S. Ueda, and Y.-B. Shi Requirement for Matrix Metalloproteinase Stromelysin-3 in Cell Migration and Apoptosis during Tissue Remodeling in Xenopus laevis J. Cell Biol., September 4, 2000; 150(5): 1177 - 1188. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Delebecq, H. Porte, F. Zerimech, M.-C. Copin, V. Gouyer, E. Dacquembronne, M. Balduyck, A. Wurtz, and G. Huet Overexpression Level of Stromelysin 3 Is Related to the Lymph Node Involvement in Non-small Cell Lung Cancer Clin. Cancer Res., March 1, 2000; 6(3): 1086 - 1092. [Abstract] [Full Text] |
||||
![]() |
M. Michael, B. Babic, R. Khokha, M. Tsao, J. Ho, M. Pintilie, K. Leco, D. Chamberlain, and F. A. Shepherd Expression and Prognostic Significance of Metalloproteinases and Their Tissue Inhibitors in Patients With Small-Cell Lung Cancer J. Clin. Oncol., June 1, 1999; 17(6): 1802 - 1802. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kataoka, H. Uchino, T. Iwamura, M. Seiki, K. Nabeshima, and M. Koono Enhanced Tumor Growth and Invasiveness in Vivo by a Carboxyl-Terminal Fragment of {alpha}1-Proteinase Inhibitor Generated by Matrix Metalloproteinases : A Possible Modulatory Role in Natural Killer Cytotoxicity Am. J. Pathol., February 1, 1999; 154(2): 457 - 468. [Abstract] [Full Text] [PDF] |
||||
![]() |
G I Murray, M E Duncan, E Arbuckle, W T Melvin, and J E Fothergill Matrix metalloproteinases and their inhibitors in gastric cancer Gut, December 1, 1998; 43(6): 791 - 797. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z von Marschall, E O Riecken, and S Rosewicz Stromelysin 3 is overexpressed in human pancreatic carcinoma and regulated by retinoic acid in pancreatic carcinoma cell lines Gut, November 1, 1998; 43(5): 692 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yoshizaki, H. Sato, M. Furukawa, and J. S. Pagano The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1 PNAS, March 31, 1998; 95(7): 3621 - 3626. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Masson, O. Lefebvre, A. Noel, M. E. Fahime, M.-P. Chenard, C. Wendling, F. Kebers, M. LeMeur, A. Dierich, J.-M. Foidart, et al. In Vivo Evidence That the Stromelysin-3 Metalloproteinase Contributes in a Paracrine Manner to Epithelial Cell Malignancy J. Cell Biol., March 23, 1998; 140(6): 1535 - 1541. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Mari, I. C. Anderson, S. E. Mari, Y. Ning, Y. Lutz, L. Kobzik, and M. A. Shipp Stromelysin-3 Is Induced in Tumor/Stroma Cocultures and Inactivated via a Tumor-specific and Basic Fibroblast Growth Factor-dependent Mechanism J. Biol. Chem., January 2, 1998; 273(1): 618 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Singer, A. Rasmussen, M. E. Lippman, and K. J. Cullen Coexpression of Stromelysin-3 and Insulin-Like Growth Factor II in Tumors of Ectodermal, Mesodermal, and Endodermal Origin: Indicator of a Fetal Cell Phenotype J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1917 - 1922. [Abstract] [Full Text] [PDF] |
||||
![]() |
O Lefebvre, C Regnier, M. Chenard, C Wendling, P Chambon, P Basset, and M. Rio Developmental expression of mouse stromelysin-3 mRNA Development, January 4, 1995; 121(4): 947 - 955. [Abstract] [PDF] |
||||
![]() |
A. Boulay, C. H. Regnier, P. Anglard, I. Stoll, C. Tomasetto, and M.-C. Rio Transcription Regulation and Protein Subcellular Localization of the Truncated Basic Hair Keratin hHb1-Delta N in Human Breast Cancer Cells J. Biol. Chem., June 15, 2001; 276(25): 22954 - 22964. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |